Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Getein Biotech Inc
603387Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. The company provides point-of-care detection of cardiac troponin I, chemiluminescence, biochemical detection, molecular detection, thrombus and hemostasis detection, blood cell analysis detection, urine analysis, quality control products, diagnostic raw materials, biochemical immunity, thrombosis and hemostasis, and other technical fields, covering cardiovascular, inflammation, kidney, thyroid function, hormone, glucose metabolism, tumor, blood cells, blood coagulation, and other detection fields. Its product applications include laboratory departments of medical institutions, emergency rooms, health examination center, community clinic, family personal health management, etc. The company was founded in 2002 and is headquartered in Nanjing, China. Address: No.9 Bofu Road, Nanjing, China, 211505
Analytics
Zielpreis von Wall Street
270.33 CNYKGV
17.74Dividendenrendite
–Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 603387
Dividenden-Analyse 603387
Dividendenwachstum über 5 Jahre
83 %Kontinuierliches Wachstum
–Ausschüttungsquote 5-Jahres-Durchschnitt
29 %Verlauf der Dividende 603387
Bewertung der Aktie 603387
Finanzen 603387
Ergebnisse | 2019 | Dynamik |